Evaluation of Serum sCD30 in Renal Transplantation Patients With and Without Acute Rejection

Transplantation Proceedings

Volumn 41, Issue 4, 2009, Pages 1159-1161

  Cervelli, C ^a   Fontecchio, G ^a   Scimitarra, M ^a   Azzarone, R ^a   Famulari, A ^b   Pisani, F ^b   Battistoni, C ^a   Di Iulio, B ^a   Fracassi, D ^a   Scarnecchia, M A ^a   Papola, F ^a  

^a ASL 4   (Italy)

^b Cattedra di Chirurgia Sostitutiva   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; CREATININE; CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RECOMBINANT INTERLEUKIN 2; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CLINICAL EVALUATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HOSPITAL ADMISSION; HUMAN; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RENAL GRAFT DYSFUNCTION; SERUM; ALLOTRANSPLANTATION; BLOOD; GRAFT REJECTION; IMMUNOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; UREMIA;

ADULT; ANTIGENS, CD30; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TRANSPLANT RECIPIENTS; TRANSPLANTATION, HOMOLOGOUS; UREMIA;

EID: 65549140598     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.03.077     Document Type: Article

References (8)

1. Gwinner W. Renal transplant rejection markers. World J Urol 25 (2007) 445
2. Ayed K., Abdallah T.B., Bardi R., et al. Plasma levels of soluble CD30 in kidney graft recipients as predictors of acute allograft rejection. Transplant Proc 38 (2006) 200
3. Schlaf G., Altermann W.W., Rothhoff A., et al. Soluble CD30 serum level - an adequate marker for allograft of solid organs?. Histol Histopathol 22 (2007) 1269
4. Süsal C., Pelzl S., Döhler B., et al. Identification of highly responsive kidney transplant recipients using pretransplant soluble CD30. J Am Soc Nephrol 13 (2002) 1650
5. Lagan L.L., Park L.P., Hughes T.L., et al. Post-transplant HLA class II antibodies and high soluble CD30 levels are independently associated with poor kidney graft survival. Am J Transplant 7 (2007) 847
6. Frisaldi E., Conca R., and Magistroni P. Prognostic values of soluble CD30 and CD30 gene polymorphisms in heart transplantation. Transplantation 81 (2006) 1153
7. Altermann W., Schlaf G., Rothhoff A., et al. High variation of individual soluble serum CD30 levels of pre-transplantation patients:sCD30 a feasible marker for prediction of kidney allograft rejection?. Nephrol Dial Transplant 22 (2007) 2795
8. Vaidya S., Partlow D., Barnes T., et al. Soluble CD30 concentrations in ESRD patients with and without panel reactive HLA antibodies. Clin Transplant 20 (2006) 461